Autoimmunity as the body’s defense mechanism against the enemy within: Development of therapeutic vaccines for neurodegenerative disorders (original) (raw)
Asghar SS, Pasch MC (2000). Therapeutic inhibition of the complement system. Y2K update. Front Biósci5: E63-E81. ArticleCASPubMed Google Scholar
Barouch R, Schwartz M (2002). Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J16: 1304–1306. CASPubMed Google Scholar
Ben-Nun A, Cohen IR (1982). Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol129: 303–308. CASPubMed Google Scholar
Bjartmar C, Trapp BD (2001). Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol14: 271–278. ArticleCASPubMed Google Scholar
Burt RK, Marmont A, et al (2000). Intense immune suppression for systemic lupus—the role of hematopoietic stem cells. J Clin Immunol20: 31–37. ArticleCASPubMed Google Scholar
Butovsky O, Hauben E, et al (2001). Morphological aspects of spinal cord autoimmune neuroprotection: colocalization of T cells with B7-2 (CD86) and prevention of cyst formation. FASEB J15: 1065–1067. CASPubMed Google Scholar
Choy EH (2000). Oral toleragens in rheumatoid arthritis. Curr Opin Invest Drugs1: 58–62. CAS Google Scholar
Duda PW, Schmied MC, et al (2000). Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J Clin Invest105: 967–976. ArticleCASPubMed Google Scholar
Farina C, Then Bergh F, et al (2001). Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferongamma response in blood cells. Brain124: 705–719. ArticleCASPubMed Google Scholar
Fisher J, Levkovitch-Verbin H, et al (2001). Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J Neurosci21: 136–142. CASPubMed Google Scholar
Greenamyre JT, MacKenzie G, et al (1999). Mitochondrial dysfunction in Parkinson’s disease. Biochem Soc Symp66: 85–97. CASPubMed Google Scholar
Hartwick AT (2001). Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy. Optom Vis Sci78: 85–94. ArticleCASPubMed Google Scholar
Hauben E, Butovsky O, et al (2000a). Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci20: 6421–6430. CASPubMed Google Scholar
Hauben E, Nevo U, et al (2000b). Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet355: 286–287. ArticleCASPubMed Google Scholar
Hovda DA, Yoshino A, et al (1991). Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study. Brain Res567: 1–10. ArticleCASPubMed Google Scholar
Kim G, Kohyama K, et al (1998). Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectra-type in the central nervous system of rats with chronic relapsing EAE. J Immunol161: 6993–6998. CASPubMed Google Scholar
Kipnis J, Hauben E, et al (2002a). Neuronal survival after central nervous system injury is improved by depletion of CD4+CD25+ regulatory T cells and worsened by neonatal tolerance to myelin proteins. Proc Natl Acad Sci USA In press.
Kipnis J, Mizrahi T, et al (2002b). Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J Neuroimmunol130: 78–850. ArticleCASPubMed Google Scholar
Kipnis J, Yoles E, et al (2000). T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci USA97: 7446–7451. ArticleCASPubMed Google Scholar
Kipnis J, Yoles E, et al (2001). Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J Neurosci21: 4564–4571. CASPubMed Google Scholar
McMurray RW (2001). Bromocriptine in rheumatic and autoimmune diseases. Semin Arthritis Rheum31: 21–32. ArticleCASPubMed Google Scholar
Meyer R, Weissert R, et al (2001). Acute neuronal apoptosis in a rat model of multiple sclerosis. J Neurosci21: 6214–6220. CASPubMed Google Scholar
Mizrahi T, Hauben E, et al (2002). The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis. J Immunol169: 5971–5977. CASPubMed Google Scholar
Moalem G, Leibowitz-Amit R, et al (1999). Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med5: 49–55. ArticleCASPubMed Google Scholar
Neuhaus O, Farina C, et al (2001). Mechanisms of action of glatiramer acetate in multiple sclerosis. Neurology56: 702–708. CASPubMed Google Scholar
Neuhaus O, Farina C, et al (2000). Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells [In Process Citation]. Proc Natl Acad Sci USA97: 7452–7457. ArticleCASPubMed Google Scholar
Olsson T, Dahlman I, et al (2000). Genetics of rat neuroinflammation. J Neuroimmunol107: 191–200. ArticleCASPubMed Google Scholar
Perry VH, Anthony DC (1999). Axon damage and repair in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci354: 1641–1647. ArticleCASPubMed Google Scholar
Poluektova LY, Munn DH, et al (2002). Generation of cytotoxid T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J Immunol168: 3941–3949. CASPubMed Google Scholar
Rothstein JD (1995a). Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv Neurol68: 7–20. CASPubMed Google Scholar
Rothstein JD (1995b). Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin Neurosci3: 348–359. PubMed Google Scholar
Schmidt S, Linington C, et al (1997). Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. Brain120: 1437–1445. ArticlePubMed Google Scholar
Schori H, Kipnis J, et al (2001a). Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci USA98: 3398–3403. ArticleCASPubMed Google Scholar
Schori H, Yoles E, et al (2001b). T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system. J Neuroimmunol119: 199–204. ArticleCASPubMed Google Scholar
Schwartz M (2001). Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines. Prog Neurobiol65: 489–496. ArticleCASPubMed Google Scholar
Schwartz M, Kipnis J (2001). Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol Med7: 252–258. ArticleCASPubMed Google Scholar
Schwartz M, Kipnis J (2002a). Autoimmunity on alert: naturally occurring regulatory CD4+CD25+ T cells as part of the evolutionary compromise between a “need” and a “risk.” Trends Immunol23: 550–5548. Article Google Scholar
Schwartz M, Kipnis J (2002b). Multiple sclerosis as a byproduct of the failure to sustain protective autoimmunity: a paradigm shift. Neuroscientist8: 405–430. ArticleCASPubMed Google Scholar
Sela M (1999a). The concept of specific immune treatment against autoimmune diseases. Int Rev Immunol18: 201–216. CASPubMed Google Scholar
Sela M (1999b). Specific vaccines against autoimmune diseases [In Process Citation]. C R Acad Sci III322: 933–938. CASPubMed Google Scholar
Wimer BM (1998). Immunosuppressive applications of PHA and other plant mitogens. Cancer Biother Radio-pharmacol13: 99–107. ArticleCAS Google Scholar
Yoles E, Hauben E, et al (2001). Protective autoimmunity is a physiological response to CNS trauma. J Neurosci21: 3740–3748. CASPubMed Google Scholar
Yoles E, Schwartz M (1998). Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp Neurol153: 1–7. ArticleCASPubMed Google Scholar